{"id":440140,"date":"2021-02-19T16:08:23","date_gmt":"2021-02-19T21:08:23","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=440140"},"modified":"2021-02-19T16:08:23","modified_gmt":"2021-02-19T21:08:23","slug":"clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/","title":{"rendered":"ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021"},"content":{"rendered":"
\n

IRVINE, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the \u201cCompany\u201d), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will release financial results for its 2020 fourth quarter and full year, which ended December 31, 2020, on Thursday, March 4, 2021, after the market close.<\/p>\n

Investors and analysts are invited to listen to a live broadcast review of the Company’s 2020 fourth quarter and full year financial results on Thursday, March 4, 2021 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) which may be accessed online here<\/a> or by visiting the Company’s website at\u00a0www.clearpointneuro.com<\/a>\u00a0and selecting \u201cInvestors\u201d \/ \u201cNews\u201d \/ \u201cIR Calendar.\u201d Investors and analysts who would like to participate in the conference call via telephone may do so at (877) 407-9034, or at (201) 493-6737 if calling from outside the U.S. or Canada.<\/p>\n

For those who cannot access the live broadcast, a replay will be available shortly after the completion of the call until Saturday, April 3, 2021 by calling (877) 660-6853, or (201) 612-7415 if calling from outside the U.S. or Canada, and then entering conference I.D. number 413671. An online archive of the broadcast will be available on the Company’s website at\u00a0www.clearpointneuro.com<\/a>, on the \u201cInvestor Relations\u201d page.<\/p>\n

\n
\n About ClearPoint Neuro<\/u>
\n <\/strong>\n <\/p>\n

ClearPoint Neuro\u2019s mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Applications of the Company\u2019s current product portfolio include deep-brain stimulation, laser ablation, biopsy, neuro-aspiration, and delivery of drugs, biologics, and gene therapy to the brain. The ClearPoint Neuro Navigation System has FDA clearance, is CE-marked, and is installed in over 60 active clinical sites in the United States, Canada, and Europe. The Company\u2019s SmartFlow\u00ae<\/sup> cannula is being used in partnership or evaluation with 25 individual biologics and drug delivery companies in various stages from preclinical research to late-stage regulatory trials. To date, more than 4,000 cases have been performed and supported by the Company\u2019s field-based clinical specialist team which offers support and services for our partners. For more information, please visit www.clearpointneuro.com<\/a>.<\/p>\n

\n
\n Forward-Looking Statements<\/u>
\n <\/strong>\n <\/p>\n

Statements herein concerning the Company\u2019s plans, growth and strategies may include forward-looking statements within the context of the federal securities laws. Statements regarding the Company’s future events, developments and future performance, as well as management’s expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. Uncertainties and risks may cause the Company’s actual results to differ materially from those expressed in or implied by forward-looking statements. Particular uncertainties and risks include those relating to: the impact of COVID-19 and the measures adopted to contain its spread; future revenues from sales of the Company\u2019s ClearPoint Neuro Navigation System products; the Company\u2019s ability to market, commercialize and achieve broader market acceptance for the Company\u2019s ClearPoint Neuro Navigation System products; and estimates regarding the sufficiency of the Company\u2019s cash resources. More detailed information on these and additional factors that could affect the Company\u2019s actual results are described in the \u201cRisk Factors\u201d section of the Company\u2019s Annual Report on Form 10-K for the year ended December 31, 2019, and the Company\u2019s Quarterly Report on Form 10-Q for the three months ended September 30, 2020, both of which have been filed with the Securities and Exchange Commission, and the Company\u2019s Annual Report on Form 10-K for the year ended December 31, 2020, which the Company intends to file with the Securities and Exchange Commission on or before March 31, 2021.<\/p>\n


\n
\n \n <\/div>\n

\n
Contact:\r\n\r\nDanilo D\u2019Alessandro, Chief Financial Officer\r\n(949) 900-6833\r\ninfo@clearpointneuro.com\u00a0\r\n\r\nJacqueline Keller, Vice President, Marketing\r\n(949) 900-6833\r\ninfo@clearpointneuro.com\u00a0<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"
IRVINE, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the \u201cCompany\u201d), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will release financial results for its 2020 fourth quarter and full year, which ended December 31, 2020, on Thursday, March 4, 2021, after the market close. Investors and analysts are invited to listen to a live broadcast review of the Company’s 2020 fourth quarter and full year financial results on Thursday, March 4, 2021 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) which may be accessed online here or by visiting the Company’s website at\u00a0www.clearpointneuro.com\u00a0and selecting \u201cInvestors\u201d \/ \u201cNews\u201d \/ \u201cIR Calendar.\u201d Investors and analysts who would like … <\/p>\n
Continue reading “ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-440140","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the \u201cCompany\u201d), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will release financial results for its 2020 fourth quarter and full year, which ended December 31, 2020, on Thursday, March 4, 2021, after the market close. Investors and analysts are invited to listen to a live broadcast review of the Company’s 2020 fourth quarter and full year financial results on Thursday, March 4, 2021 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) which may be accessed online here or by visiting the Company’s website at\u00a0www.clearpointneuro.com\u00a0and selecting \u201cInvestors\u201d \/ \u201cNews\u201d \/ \u201cIR Calendar.\u201d Investors and analysts who would like … Continue reading "ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-19T21:08:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjMzNCMzOTg1ODUwIzIwMjcxMjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021\",\"datePublished\":\"2021-02-19T21:08:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\\\/\"},\"wordCount\":598,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjMzNCMzOTg1ODUwIzIwMjcxMjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\\\/\",\"name\":\"ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjMzNCMzOTg1ODUwIzIwMjcxMjA=\",\"datePublished\":\"2021-02-19T21:08:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjMzNCMzOTg1ODUwIzIwMjcxMjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjMzNCMzOTg1ODUwIzIwMjcxMjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/","og_locale":"en_US","og_type":"article","og_title":"ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021 - Market Newsdesk","og_description":"IRVINE, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the \u201cCompany\u201d), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will release financial results for its 2020 fourth quarter and full year, which ended December 31, 2020, on Thursday, March 4, 2021, after the market close. Investors and analysts are invited to listen to a live broadcast review of the Company’s 2020 fourth quarter and full year financial results on Thursday, March 4, 2021 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) which may be accessed online here or by visiting the Company’s website at\u00a0www.clearpointneuro.com\u00a0and selecting \u201cInvestors\u201d \/ \u201cNews\u201d \/ \u201cIR Calendar.\u201d Investors and analysts who would like … Continue reading \"ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-19T21:08:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjMzNCMzOTg1ODUwIzIwMjcxMjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021","datePublished":"2021-02-19T21:08:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/"},"wordCount":598,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjMzNCMzOTg1ODUwIzIwMjcxMjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/","name":"ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjMzNCMzOTg1ODUwIzIwMjcxMjA=","datePublished":"2021-02-19T21:08:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjMzNCMzOTg1ODUwIzIwMjcxMjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjMzNCMzOTg1ODUwIzIwMjcxMjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2020-results-on-march-4-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/440140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=440140"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/440140\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=440140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=440140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=440140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}